WCN26-2002 SYNERGISTIC ERYTHROPOIETIC EFFECTS AND SAFETY PROFILE OF PEGMOLESATIDE COMBINED WITH ROXADUSTAT IN PRECLINICAL MODELS OF CHRONIC KIDNEY DISEASE-ASSOCIATED ANEMIA
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
WCN26-2002 SYNERGISTIC ERYTHROPOIETIC EFFECTS AND SAFETY PROFILE OF PEGMOLESATIDE COMBINED WITH ROXADUSTAT IN PRECLINICAL MODELS OF CHRONIC KIDNEY DISEASE-ASSOCIATED ANEMIA | Researchclopedia